Prognostic value of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) in patients with RAS-mutant metastatic colorectal cancer
NHHR may serve as a potential prognostic biomarker in patients with RAS-mutant metastatic colorectal cancer. Its putative role in promoting tumor progression through modulation of chronic inflammation warrants further investigation.
Authors
- Yunjiao Shi
- Bin Liang (ORCID: https://orcid.org/0000-0001-9131-5478)
- Ruoyun Wang (ORCID: https://orcid.org/0000-0003-2230-0728)
- Shayan Wang (ORCID: https://orcid.org/0000-0001-9721-0132)
- Wenxia Xie (ORCID: https://orcid.org/0009-0004-3353-329X)
- Bingxin Zhang (ORCID: https://orcid.org/0000-0003-2617-0588)
- Huizhuo Liu
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2025-10-31
- DOI
- https://doi.org/10.3389/fnut.2025.1617930
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00